O-3 Efficacy and safety of entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis of three clinical trials (STARTRK-2, STARTRK-1 and ALKA-372-001)
Authors:
- M. PatelMPM. Patel
- S. SienaSSS. Siena
- G. DemetriGDG. Demetri
- R. DoebeleRDR. Doebele
- Y. ChaeYCY. Chae
- P. ConklingPCP. Conkling
- I. Garrido-LagunaIGI. Garrido-Laguna
- F. LongoFLF. Longo
- C. RolfoCRC. Rolfo
- D. SigalDSD. Sigal
- A. DrilonADA. Drilon
- S. LiuSLS. Liu
- 1 July 2020
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 31, 232-233
Abstract
No abstract availableFunding Information
- F. Hoffmann-La Roche